What is iRadimed's cash ratio?

iRadimed (IRMD) reported cash ratio of 4.7× in Q1 2026.

How has iRadimed's cash ratio changed year-over-year?

iRadimed's cash ratio decreased by 21.7% year-over-year, from 5.9× to 4.7×.

What is the long-term trend for iRadimed's cash ratio?

Over 5 years (2020 to 2025), iRadimed's cash ratio has grown at a -13.2% compound annual growth rate (CAGR), from 10.2× to 5×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

iRadimed IRMD Cash ratio

Cash ratio at other companies

Merit Medical SystemsMMSI

2.3×+0.2×

ICU MedicalICUI

0.6×0.0×

ITG

Integer HoldingsITGR

0×-0.1×

Lumexa Imaging Holdings, Inc. LMRI

0.3×—

RadNetRDNT

0.7×-0.7×

iRhythm Holdings, Inc. IRTC

1.9×-1.6×

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.21B+63.4%

P/E51.3×+13.8×

P/S14×+4.2×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Debt / equity0×0.0×

Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

cash and equivalents/total current liabilities=4.7×

Based on the most recent quarter.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's cash ratio?: iRadimed (IRMD) reported cash ratio of 4.7× in Q1 2026.
How has iRadimed's cash ratio changed year-over-year?: iRadimed's cash ratio decreased by 21.7% year-over-year, from 5.9× to 4.7×.
What is the long-term trend for iRadimed's cash ratio?: Over 5 years (2020 to 2025), iRadimed's cash ratio has grown at a -13.2% compound annual growth rate (CAGR), from 10.2× to 5×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.